Merck is testing a confluence of potential chart support near the $55 level. The stock of pharmaceutical company Merck (ticker, MRK) has been bloodied a…
Tagged $MRK
Does Chart Hold Prescription For Bounce In This Drug Stock? (PREMIUM)
This content is only available to subscribers. Sign up today!
Pharma Phall Phinding Phulcrum?
Beleaguered pharmaceutical stocks have hit our targeted downside level that could inspire a bounce, at least. Just as there are leading stocks, sectors, etc. on…
Another Health Care Chart Looks Sick
A popular pharmaceutical ETF is testing its (ill-fated?) post-2009 bull market trendline. As the major stock averages continue to bide their time in sideways fashion,…
A Breakdown Here In This Sector Would Not Be Healthy
The post-2009 bull market in drug stocks is currently being threatened. In the midst of the selling pressure last week, we mentioned that several indices…
The Long & Short (Term) Of The Pharmaceutical Sector
We have written many times about the challenge of weighing positive vs.negative inputs when analyzing the attractiveness of the investment climate. Often times, that applies…